Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-11-002398
Filing Date
2011-10-14
Accepted
2011-10-13 19:41:26
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 JINZANGHUANG TIBET PHARMACEUTICALS, INC. FORM 10-K JUNE 30, 2011 jzhg10-k20110630.htm 10-K 939482
2 AMENDED AND RESTATED SHARE PLEDGE AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TA ex10-b.htm EX-10.B 191497
3 AMENDED AND RESTATED CALL OPTION AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TAI ex10-c.htm EX-10.C 209936
4 AMENDED AND RESTATED PROXY AGREEMENT DATED JULY 24, 2009 AMONG BEIJING TAIBODEKA ex10-d.htm EX-10.D 123754
5 RULE 13A-14(A) CERTIFICATION - CEO ex311.htm EX-31.1 10025
6 RULE 13A-14(A) CERTIFICATION - CFO ex312.htm EX-31.2 10526
7 RULE 13A-14(B) CERTIFICATIONS ex32.htm EX-32 5824
  Complete submission text file 0001096906-11-002398.txt   1492282
Mailing Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311
Business Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311 201-882-3332
JINZANGHUANG TIBET PHARMACEUTICALS, INC. (Filer) CIK: 0000910832 (see all company filings)

EIN.: 262443288 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-53254 | Film No.: 111140504
SIC: 6770 Blank Checks